The authors also observed that one third of patients received psychotropic medications after being diagnosed with GD and the majority had worse cognition and neuropsychiatric symptoms after achievement of peripheral normalized thyroid hormone levels compared to their baseline (i.e. before the onset of thyrotoxicosis). The gene discussed is TG; the disease is thyrotoxicosis.